News Snapshot:
Kanger Gets Biotechnology Board S Greenlight On China Covid 19 Vaccine Kanger Gets Biotechnology Board S Greenlight On China Covid 19 Vaccine COVID-19 | Kanger International Berhad announced that the National Institutes of Biotechnology Malaysia (NIBM) has issued a letter stating it has no objections for the company to communicate with Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.This followed Kanger’s announcement on Sept 29 that the group, which is chaired by former deputy minister Nur Jazlan Mohamed, entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd.The deal is for the distribution...
